Fibroblast growth factor 23
| GO Term |
|---|
| extracellular region |
| extracellular space |
| cytoplasm |
| endoplasmic reticulum lumen |
| Golgi lumen |
| GO Term |
|---|
| type 1 fibroblast growth factor receptor binding |
| growth factor activity |
| Pathway Name | Organism |
|---|---|
| Activated point mutants of FGFR2 | Homo sapiens |
| Constitutive Signaling by Aberrant PI3K in Cancer | Homo sapiens |
| Downstream signaling of activated FGFR1 | Homo sapiens |
| FGFR1c and Klotho ligand binding and activation | Homo sapiens |
| FGFR1c ligand binding and activation | Homo sapiens |
| FGFR2c ligand binding and activation | Homo sapiens |
| FGFR3c ligand binding and activation | Homo sapiens |
| FGFR4 ligand binding and activation | Homo sapiens |
| FGFRL1 modulation of FGFR1 signaling | Homo sapiens |
| FRS-mediated FGFR1 signaling | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0050948 | autosomal dominant hypophosphatemic rickets |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025